Launch of report 'Monitoring the elimination of HCV and HBV as a public health threat among PWID in Europe' - The elimination barometer

In 2016, the World Health Assembly endorsed the first Global Health Sector Strategy on viral hepatitis. The aim of the strategy is to eliminate viral hepatitis as a major public health threat by 2030. In Europe, people who inject drugs (PWID) are at high risk of HCV and HBV transmission and constitute a key group for the elimination strategy. Chronic viral hepatitis can result in serious liver disease such as cirrhosis and cancer and is associated with a high burden of disease. As a complement to the existing monitoring platform, the European Monitoring Centre for Drugs and Drug Addiction is working with its expert network on drug-related infectious diseases (DRID network) on a PWID-specific list of epidemiological indicators – the elimination barometer - in order to support member states to identify data gaps and to assess the progress towards elimination of HCV and HBV in this group.